Mobiliar took part in a $35m round for medicine transportation system developer SkyCell while Nice Investment co-led wealth management software provider Fount's $33.4m series C.

Funding SkyCell, a Switzerland-based developer of cold-chain pharmaceutical transport systems, received $35m in series C funding yesterday from investors including insurance firm Mobiliar. Investment holding company ADQ’s DisruptAD also took part in the round, as did Shuaa Capital and unnamed family offices, while a Swiss cantonal bank supplied a debt facility of undisclosed size. MVM…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.